- Indoxyl sulfate, homocysteine, and antioxidant capacities in patients at different stages of chronic kidney disease
-
Chen CH, Huang SC, Yeh EL, Lin PC, Tsai SF, Huang YC
- KMID: 2532096
- Nutr Res Pract.
- 2022 Aug;16(4):464-475.
- doi: 10.4162/nrp.2022.16.4.464
BACKGROUND/OBJECTIVES: Increased levels of uremic toxins and decreased antioxidant capacity have a significant impact on the progression of chronic kidney disease (CKD). However, it remains unclear whether they interact with... -
- CITED
-
- Close
- SHARE
-
- Close
